COVID-19 drug treatments.”The team is hoping that the development will allow pharmaceutical companies to rapidly screen a bunch of potential drug treatments for COVID-19, speeding up the process of approving new treatments.
Coronavirus: meet the Ontario researchers responsible for 3 world-firsts Principal investigator Abdulla Mahboob’s team has developed a special kind of artificial copy of the SARS-CoV-2 virus, which causes COVID-19, that researchers can use to rapidly test treatments without having to use expensive materials in a high level laboratory.A non-infectious copy is called a replicon and they’ve been used with many viruses before.